Transforming Drug Discovery: Leveraging Deep Learning and NLP for Accelerated Drug Repurposing through Text Mining in Biomedical Literature
Keywords:
drug repurposing, drug repositioning, text mining, deep learning, natural language processing, biomedical literature, drug discoveryAbstract
Drug repurposing or drug repositioning aims to find new uses for existing drugs, providing a faster and more cost-effective approach to drug development compared to traditional methods. Rapid advancements in deep learning and natural language processing (NLP) methods present new opportunities to accelerate drug repurposing through automated analysis of biomedical literature. This paper provides a comprehensive review of recent applications of deep learning and NLP for drug repurposing through text mining of biomedical corpora. We describe the motivations, challenges, and trends in this exciting field, summarize key techniques, and present illustrative case studies. Promising directions for continued research are also discussed. Overall, this paper demonstrates how deep learning and NLP are transforming drug discovery by enabling large-scale mining of biomedical text to uncover hidden relationships between drugs, diseases, targets, and mechanisms.
Downloads
References
Chen, W.; Liu, X.; Zhang, S.; Chen, S. Artificial intelligence for drug discovery: Resources, methods, and applications. Mol. Ther. Nucl. Acids 2023, 31, 691–702.
Cifci, M.A. A Deep Learning-Based Framework for Uncertainty Quantification in Medical Imaging Using the DropWeak Technique: An Empirical Study with Baresnet. Diagnostics 2023, 13, 800.
Wong, J.H.; Zhang, Q.X. Deep Learning of Sparse Patterns in Medical IoT for Efficient Big Data Harnessing. IEEE Access 2023, 11, 25856–25864. [Google Scholar] [CrossRef]
Alya, A.A. Artificial intelligence in drug design: Algorithms, applications, challenges and ethics. Future Drug Discov. 2021, 3, FDD59. [Google Scholar] [CrossRef]
Gupta, R.; Srivastava, D.; Sahu, M.; Tiwari, S.; Ambasta, R.K.; Kumar, P. Artificial intelligence to deep learning: Machine intelligence approach for drug discovery. Mol. Divers 2021, 25, 1315–1360. [Google Scholar] [CrossRef]
Zhu, H. Big Data and Artificial Intelligence Modeling for Drug Discovery. Annu. Rev. Pharmacol. 2020, 60, 573–589. [Google Scholar] [CrossRef]
Hu, Y.; Lu, Y.; Wang, S.; Zhang, M.Y.; Qu, X.S.; Niu, B. Application of Machine Learning Approaches for the Design and Study of Anticancer Drugs. Curr. Drug Targets 2019, 20, 488–500. [Google Scholar] [CrossRef]
Tong, X.C.; Liu, X.H.; Tan, X.Q.; Li, X.T.; Jiang, J.X.; Xiong, Z.P.; Xu, T.Y.; Jiang, H.L.; Qiao, N.; Zheng, M.Y. Generative Models for De Novo Drug Design. J. Med. Chem. 2021, 64, 14011–14027. [Google Scholar] [CrossRef]
Cheng, Y.; Gong, Y.S.; Liu, Y.S.; Song, B.S.; Zou, Q. Molecular design in drug discovery: A comprehensive review of deep generative models. Brief Bioinform. 2021, 22, bbab344. [Google Scholar] [CrossRef]
Xue, D.Y.; Gong, Y.K.; Yang, Z.Y.; Chuai, G.H.; Qu, S.; Shen, A.Z.; Yu, J.; Liu, Q. Advances and challenges in deep generative models for de novo molecule generation. Wires Comput. Mol. Sci. 2019, 9, e1395. [Google Scholar] [CrossRef]
Vemula, D.; Jayasurya, P.; Sushmitha, V.; Kumar, Y.N.; Bhandari, V. CADD, AI and ML in drug discovery: A comprehensive review. Eur. J. Pharm. Sci. 2023, 181, 106324.
Cerchia, C.; Lavecchia, A. New avenues in artificial-intelligence-assisted drug discovery. Drug Discov. Today 2023, 28, 103516.
Dara, S.; Dhamercherla, S.; Jadav, S.S.; Babu, C.H.M.; Ahsan, M.J. Machine Learning in Drug Discovery: A Review. Artif. Intell. Rev. 2022, 55, 1947–1999.
Priya, S.; Tripathi, G.; Singh, D.B.; Jain, P.; Kumar, A. Machine learning approaches and their applications in drug discovery and design. Chem. Biol. Drug Des. 2022, 100, 136–153. [Google Scholar] [CrossRef]
Guedes, I.A.; Barreto, A.M.S.; Marinho, D.; Krempser, E.; Kuenemann, M.A.; Sperandio, O.; Dardenne, L.E.; Miteva, M.A. New machine learning and physics-based scoring functions for drug discovery. Sci. Rep. 2021, 11, 3198. [Google Scholar] [CrossRef]
Tamura, S.; Miyao, T.; Bajorath, J. Large-scale prediction of activity cliffs using machine and deep learning methods of increasing complexity. J. Cheminform. 2023, 15, 4. [Google Scholar] [CrossRef]
Stumpfe, D.; Hu, H.B.; Bajorath, J. Advances in exploring activity cliffs. J. Comput. Aid. Mol. Des. 2020, 34, 929–942. [Google Scholar] [CrossRef]
Heikamp, K.; Hu, X.Y.; Yan, A.X.; Bajorath, J. Prediction of Activity Cliffs Using Support Vector Machines. J. Chem. Inf. Model 2012, 52, 2354–2365. [Google Scholar] [CrossRef]
Rodriguez-Perez, R.; Bajorath, J. Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery. J. Comput. Aid. Mol. Des. 2022, 36, 355–362. [Google Scholar] [CrossRef]
Warszycki, D.; Struski, L.; Smieja, M.; Kafel, R.; Kurczab, R. Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design. J. Chem. Inf. Model 2021, 61, 5054–5065. [Google Scholar] [CrossRef]
Jayaraj, P.B.; Jain, S. Ligand based virtual screening using SVM on GPU. Comput. Biol. Chem. 2019, 83, 107143.
Ogura, K.; Sato, T.; Tuki, H.; Honma, T. Support Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II. Sci. Rep. 2019, 9, 12220.
Rodriguez-Perez, R.; Vogt, M.; Bajorath, J. Support Vector Machine Classification and Regression Prioritize Different Structural Features for Binary Compound Activity and Potency Value Prediction. ACS Omega 2017, 2, 6371–6379.
Sanchez-Cruz, N.; Medina-Franco, J.L. Epigenetic Target Profiler: A Web Server to Predict Epigenetic Targets of Small Molecules. J. Chem. Inf. Model 2021, 61, 1550–1554. [Google Scholar] [CrossRef]
Tong, Z.; Zhou, Y.; Wang, J. Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine. Sci. Rep. 2019, 9, 10442. [Google Scholar] [CrossRef]
Kwon, S.; Bae, H.; Jo, J.; Yoon, S. Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinform. 2019, 20, 521. [Google Scholar] [CrossRef]
Hou, T.L.; Bian, Y.M.; McGuire, T.; Xie, X.Q. Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence. Biomolecules 2021, 11, 870. [Google Scholar] [CrossRef]
Kaiser, T.M.; Burger, P.B.; Butch, C.J.; Pelly, S.C.; Liotta, D.C. A Machine Learning Approach for Predicting HIV Reverse Transcriptase Mutation Susceptibility of Biologically Active Compounds. J. Chem. Inf. Model 2018, 58, 1544–1552. [Google Scholar] [CrossRef]
Hu, J.; Zhou, L.W.; Li, B.; Zhang, X.L.; Chen, N.S. Improve hot region prediction by analyzing different machine learning algorithms. BMC Bioinform. 2021, 22, 522. [Google Scholar] [CrossRef]
Celebi, R.; Uyar, H.; Yasar, E.; Gumus, O.; Dikenelli, O.; Dumontier, M. Evaluation of knowledge graph embedding approaches for drug-drug interaction prediction in realistic settings. BMC Bioinform. 2019, 20, 726. [Google Scholar] [CrossRef]
Cai, C.P.; Guo, P.F.; Zhou, Y.D.; Zhou, J.W.; Wang, Q.; Zhang, F.X.; Fang, J.S.; Cheng, F.X. Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity. J. Chem. Inf. Model 2019, 59, 1073–1084.
Madhukar, N.S.; Khade, P.K.; Huang, L.D.; Gayvert, K.; Galletti, G.; Stogniew, M.; Allen, J.E.; Giannakakou, P.; Elemento, O. A Bayesian machine learning approach for drug target identification using diverse data types. Nat. Commun. 2019, 10, 5221. [Google Scholar] [CrossRef]
Saha, S.; Chatterjee, P.; Halder, A.K.; Nasipuri, M.; Basu, S.; Plewczynski, D. ML-DTD: Machine Learning-Based Drug Target Discovery for the Potential Treatment of COVID-19. Vaccines 2022, 10, 1643.
Khan, A.K.A.; Malim, N.H.A.H. Comparative Studies on Resampling Techniques in Machine Learning and Deep Learning Models for Drug-Target Interaction Prediction. Molecules 2023, 28, 1663.
Carpenter, K.A.; Huang, X.D. Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review. Curr. Pharm. Des. 2018, 24, 3347–3358.
Zakharov, A.V.; Varlamova, E.V.; Lagunin, A.A.; Dmitriev, A.V.; Muratov, E.N.; Fourches, D.; Kuz’min, V.E.; Poroikov, V.V.; Tropsha, A.; Nicklaus, M.C. QSAR Modeling and Prediction of Drug-Drug Interactions. Mol. Pharm. 2016, 13, 545–556.
Chen, A.Y.; Lee, J.; Damjanovic, A.; Brooks, B.R. Protein pK(a) Prediction by Tree-Based Machine Learning. J. Chem. Theory Comput. 2022, 18, 2673–2686. [Google Scholar] [CrossRef]
Cooper, K.; Baddeley, C.; French, B.; Gibson, K.; Golden, J.; Lee, T.; Pierre, S.; Weiss, B.; Yang, J. Novel Development of Predictive Feature Fingerprints to Identify Chemistry-Based Features for the Effective Drug Design of SARS-CoV-2 Target Antagonists and Inhibitors Using Machine Learning. ACS Omega 2021, 6, 4857–4877. [Google Scholar] [CrossRef]
Current status of Baricitnib as a repurposed therapy for COVID 19 by Maha saber -ayad et Al Jul 2021 Repurposing itraconazole for the treatment of cancer by Rachel pounds et al, Sep 2017
Chintala, S. K., et al. (2022). AI in public health: Modeling disease spread and management strategies. NeuroQuantology, 20(8), 10830-10838. doi:10.48047/nq.2022.20.8.nq221111
Chintala, S. K., et al. (2021). Explore the impact of emerging technologies such as AI, machine learning, and blockchain on transforming retail marketing strategies. Webology, 18(1), 2361-2375.http://www.webology.org
Chintala, S. (2022). Data Privacy and Security Challenges in AI-Driven Healthcare Systems in India. Journal of Data Acquisition and Processing, 37(5), 2769-2778. https://sjcjycl.cn/ DOI: 10.5281/zenodo.7766 https://sjcjycl.cn/article/view-2022/2769.php
Chintala, S. (2023). AI-Driven Personalised Treatment Plans: The Future of Precision Medicine. Machine Intelligence Research, 17(02), 9718-9728. ISSN: 2153-182X, E-ISSN: 2153-1838. https://machineintelligenceresearchs.com/Volume-250.php
Chintala, S. (2019). IoT and Cloud Computing: Enhancing Connectivity. International Journal of New Media Studies (IJNMS), 6(1), 18-25. ISSN: 2394-4331. https://ijnms.com/index.php/ijnms/article/view/208/172
Chintala, S. (2018). Evaluating the Impact of AI on Mental Health Assessments and Therapies. EDUZONE: International Peer Reviewed/Refereed Multidisciplinary Journal (EIPRMJ), 7(2), 120-128. ISSN: 2319-5045. Available online at: www.eduzonejournal.com
Chintala, S. (2023). Improving Healthcare Accessibility with AI-Enabled Telemedicine Solutions. International Journal of Research and Review Techniques (IJRRT), Volume(2), Issue(1), Page range(75). Retrieved from https://ijrrt.com.
Chintala, S. (2020). The Role of AI in Predicting and Managing Chronic Diseases. International Journal of New Media Studies (IJNMS), Volume(7), Issue(2), Page range(16-22). ISSN: 2394-4331. Impact Factor: 6.789.
Chintala, S. (2021). Evaluating the Impact of AI and ML on Diagnostic Accuracy in Radiology. EDUZONE: International Peer Reviewed/Refereed Multidisciplinary Journal (EIPRMJ), Volume(10), Issue(1), Page range(68-75). ISSN: 2319-5045. Impact Factor: 7.687. Retrieved from www.eduzonejournal.com
Chintala, S. (2022). AI in Personalized Medicine: Tailoring Treatment Based on Genetic Information. Community Practitioner, 21(1), 141-149. ISSN 1462-2815.www.commprac.com
Rao, D. D. (2009, November 25). Multimedia-based intelligent content networking for future internet. In Proceedings of the 2009 Third UKSim European Symposium on Computer Modeling and Simulation (pp. 55-59). IEEE.
Deshpande, A., Arshey, M. R., Ravuri, D., Rao, D. D., Raja, E., & Rao, D. C. (2023). Optimizing Routing in Nature-Inspired Algorithms to Improve Performance of Mobile Ad-Hoc Network. International Journal of INTELLIGENT SYSTEMS AND APPLICATIONS IN ENGINEERING, 508–516. IJISAE. ISSN: 2147-6799.
Arunan, T., Lele, A. M., Naniyat, A., Rao, D. D., & Won, E.-T. (2009). Method and system for managing data in a near field communication network. U.S. Patent No. US8892032B2.
Thapliyal, A., Bhagavathi, P. S., Arunan, T., & Rao, D. D. (2009, January 10). Realizing zones using UPnP. In 2009 6th IEEE Consumer Communications and Networking Conference (pp. 1-5). IEEE.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
